1. Home
  2. PRU vs IQV Comparison

PRU vs IQV Comparison

Compare PRU & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prudential Financial Inc.

PRU

Prudential Financial Inc.

HOLD

Current Price

$124.78

Market Cap

42.4B

Sector

Finance

ML Signal

HOLD

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

HOLD

Current Price

$236.50

Market Cap

35.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRU
IQV
Founded
1875
1982
Country
United States
United States
Employees
N/A
93000
Industry
Life Insurance
Biotechnology: Commercial Physical & Biological Resarch
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
42.4B
35.1B
IPO Year
2001
2013

Fundamental Metrics

Financial Performance
Metric
PRU
IQV
Price
$124.78
$236.50
Analyst Decision
Hold
Strong Buy
Analyst Count
15
16
Target Price
$103.71
$227.13
AVG Volume (30 Days)
1.7M
1.4M
Earning Date
05-05-2026
05-05-2026
Dividend Yield
5.81%
N/A
EPS Growth
33.20
4.67
EPS
4.48
1.61
Revenue
$60,774,000,000.00
$9,739,000,000.00
Revenue This Year
N/A
$6.77
Revenue Next Year
$3.06
$5.89
P/E Ratio
$27.85
$150.02
Revenue Growth
N/A
41.60
52 Week Low
$91.89
$154.50
52 Week High
$127.72
$251.36

Technical Indicators

Market Signals
Indicator
PRU
IQV
Relative Strength Index (RSI) 67.70 61.19
Support Level $99.91 $220.71
Resistance Level $127.72 $247.52
Average True Range (ATR) 2.64 8.04
MACD -0.20 -0.45
Stochastic Oscillator 70.37 42.46

Price Performance

Historical Comparison
PRU
IQV

About PRU Prudential Financial Inc.

Prudential Financial is one of the largest US life insurers, offering annuities, life insurance, and asset-management products. The United States and Japan are its two largest markets. Its US business contributed about 50% of adjusted 2025 earnings and includes institutional retirement (mostly pension risk transfer), individual retirement (annuities), group insurance, and individual life insurance. Its international business represented about 39% of adjusted earnings, with a strong market position in Japan, and the firm also has a presence in emerging markets like Brazil. The company's investment management business, PGIM, contributed approximately 11% of its 2025 adjusted earnings. PGIM had around $1.47 trillion in assets under management at the end of fourth-quarter 2025.

About IQV IQVIA Holdings Inc.

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

Share on Social Networks: